Sharecare, Inc. (NASDAQ: SHCRW) Stock Competitors & Peer Comparison
See SHCRW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SHCRW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SHCRW | $0.09 | +4.41% | 32.5M | -0.00 | -$19.38 | N/A |
| VEEV | $179.58 | -2.69% | 29.2B | 21.57 | $8.33 | N/A |
| GEHC | $61.99 | +0.94% | 28.2B | 13.59 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $69.84 | +0.14% | 13.7B | 56.32 | $1.24 | N/A |
| BTSGU | $230.25 | +0.48% | 13.7B | 207.29 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $46.01 | -2.02% | 8B | -92.02 | -$0.50 | N/A |
| HQY | $94.33 | -1.69% | 7.9B | 22.04 | $4.28 | N/A |
| TXG | $48.06 | +2.15% | 6.1B | -282.71 | -$0.17 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
SHCRW vs VEEV Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, VEEV has a market cap of 29.2B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while VEEV trades at $179.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas VEEV's P/E ratio is 21.57. In terms of profitability, SHCRW's ROE is -0.25%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, SHCRW is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SHCRW vs GEHC Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while GEHC trades at $61.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas GEHC's P/E ratio is 13.59. In terms of profitability, SHCRW's ROE is -0.25%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SHCRW is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
SHCRW vs GEHCV Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SHCRW is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
SHCRW vs BTSG Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, BTSG has a market cap of 13.7B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while BTSG trades at $69.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas BTSG's P/E ratio is 56.32. In terms of profitability, SHCRW's ROE is -0.25%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
SHCRW vs BTSGU Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, BTSGU has a market cap of 13.7B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while BTSGU trades at $230.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas BTSGU's P/E ratio is 207.29. In terms of profitability, SHCRW's ROE is -0.25%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
SHCRW vs SGFY Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SHCRW's ROE is -0.25%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SHCRW is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
SHCRW vs TEM Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, TEM has a market cap of 8B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while TEM trades at $46.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas TEM's P/E ratio is -92.02. In terms of profitability, SHCRW's ROE is -0.25%, compared to TEM's ROE of -0.70%. Regarding short-term risk, SHCRW is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
SHCRW vs HQY Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HQY trades at $94.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HQY's P/E ratio is 22.04. In terms of profitability, SHCRW's ROE is -0.25%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SHCRW is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
SHCRW vs TXG Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, TXG has a market cap of 6.1B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while TXG trades at $48.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas TXG's P/E ratio is -282.71. In terms of profitability, SHCRW's ROE is -0.25%, compared to TXG's ROE of -0.03%. Regarding short-term risk, SHCRW is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check TXG's competition here
R1 RCM Inc. (NASDAQ: RCM)
SHCRW vs RCM Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas RCM's P/E ratio is -102.21. In terms of profitability, SHCRW's ROE is -0.25%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SHCRW is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check RCM's competition here
Hinge Health, Inc. (NYSE: HNGE)
SHCRW vs HNGE Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HNGE has a market cap of 5.9B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HNGE trades at $76.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HNGE's P/E ratio is 39.26. In terms of profitability, SHCRW's ROE is -0.25%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, SHCRW is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HNGE's competition here
Doximity, Inc. (NYSE: DOCS)
SHCRW vs DOCS Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while DOCS trades at $20.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas DOCS's P/E ratio is 13.36. In terms of profitability, SHCRW's ROE is -0.25%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, SHCRW is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
SHCRW vs ONEM Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SHCRW's ROE is -0.25%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SHCRW is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
SHCRW vs PRVA Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while PRVA trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas PRVA's P/E ratio is 156.06. In terms of profitability, SHCRW's ROE is -0.25%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, SHCRW is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
SHCRW vs PGNY Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while PGNY trades at $30.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas PGNY's P/E ratio is 22.41. In terms of profitability, SHCRW's ROE is -0.25%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, SHCRW is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
SHCRW vs HTFL Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HTFL trades at $24.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HTFL's P/E ratio is -12.24. In terms of profitability, SHCRW's ROE is -0.25%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SHCRW is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
SHCRW vs WGS Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while WGS trades at $63.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas WGS's P/E ratio is 74.56. In terms of profitability, SHCRW's ROE is -0.25%, compared to WGS's ROE of -0.28%. Regarding short-term risk, SHCRW is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check WGS's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
SHCRW vs NXGN Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SHCRW's ROE is -0.25%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SHCRW is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
SHCRW vs TDOC Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while TDOC trades at $8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas TDOC's P/E ratio is -9.62. In terms of profitability, SHCRW's ROE is -0.25%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, SHCRW is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
SHCRW vs AGTI Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SHCRW's ROE is -0.25%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SHCRW is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
SHCRW vs OMDA Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while OMDA trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas OMDA's P/E ratio is 302.86. In terms of profitability, SHCRW's ROE is -0.25%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, SHCRW is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
SHCRW vs CERT Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CERT trades at $7.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CERT's P/E ratio is 18.23. In terms of profitability, SHCRW's ROE is -0.25%, compared to CERT's ROE of -0.01%. Regarding short-term risk, SHCRW is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
SHCRW vs GDRX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, GDRX has a market cap of 994.8M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while GDRX trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas GDRX's P/E ratio is 8.70. In terms of profitability, SHCRW's ROE is -0.25%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SHCRW is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
SHCRW vs CCLDO Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
SHCRW vs HSTM Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HSTM has a market cap of 771M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HSTM trades at $26.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HSTM's P/E ratio is 34.72. In terms of profitability, SHCRW's ROE is -0.25%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SHCRW is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HSTM's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
SHCRW vs MPLN-WT Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, SHCRW is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check MPLN-WT's competition here
Phreesia, Inc. (NYSE: PHR)
SHCRW vs PHR Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, PHR has a market cap of 607M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while PHR trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas PHR's P/E ratio is 35.07. In terms of profitability, SHCRW's ROE is -0.25%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SHCRW is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check PHR's competition here
Accolade, Inc. (NASDAQ: ACCD)
SHCRW vs ACCD Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SHCRW's ROE is -0.25%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SHCRW is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
SHCRW vs SHCR Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SHCRW's ROE is -0.25%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SHCRW is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
SHCRW vs EVH Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, EVH has a market cap of 519.7M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while EVH trades at $4.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas EVH's P/E ratio is 462.00. In terms of profitability, SHCRW's ROE is -0.25%, compared to EVH's ROE of -0.78%. Regarding short-term risk, SHCRW is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check EVH's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
SHCRW vs WGSWW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas WGSWW's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, SHCRW is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check WGSWW's competition here
NRC Health (NASDAQ: NRC)
SHCRW vs NRC Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, NRC has a market cap of 469.4M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while NRC trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas NRC's P/E ratio is 25.40. In terms of profitability, SHCRW's ROE is -0.25%, compared to NRC's ROE of +0.57%. Regarding short-term risk, SHCRW is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
SHCRW vs SOPH Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SOPH has a market cap of 415.9M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SOPH trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SOPH's P/E ratio is -11.63. In terms of profitability, SHCRW's ROE is -0.25%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, SHCRW is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
SHCRW vs SLGCW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SHCRW's ROE is -0.25%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SHCRW is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
SHCRW vs SLGC Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SHCRW's ROE is -0.25%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SHCRW is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SLGC's competition here
Claritev Corporation (NYSE: CTEV)
SHCRW vs CTEV Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CTEV has a market cap of 396.2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CTEV trades at $23.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CTEV's P/E ratio is -1.78. In terms of profitability, SHCRW's ROE is -0.25%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, SHCRW is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check CTEV's competition here
TruBridge, Inc. (NASDAQ: TBRG)
SHCRW vs TBRG Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SHCRW's ROE is -0.25%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SHCRW is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
SHCRW vs MPLN Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SHCRW's ROE is -0.25%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, SHCRW is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
SHCRW vs SLP Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SLP has a market cap of 370.7M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SLP trades at $18.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SLP's P/E ratio is 20.83. In terms of profitability, SHCRW's ROE is -0.25%, compared to SLP's ROE of +0.06%. Regarding short-term risk, SHCRW is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
SHCRW vs TRHC Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SHCRW's ROE is -0.25%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SHCRW is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
SHCRW vs SY Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SY has a market cap of 251.9M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SY trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SY's P/E ratio is -5.82. In terms of profitability, SHCRW's ROE is -0.25%, compared to SY's ROE of -0.16%. Regarding short-term risk, SHCRW is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
SHCRW vs SMFR Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SMFR's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, SHCRW is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
SHCRW vs SPOK Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SPOK has a market cap of 219.5M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SPOK trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SPOK's P/E ratio is 17.52. In terms of profitability, SHCRW's ROE is -0.25%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SHCRW is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
SHCRW vs AMWL Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, AMWL has a market cap of 181.1M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while AMWL trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas AMWL's P/E ratio is -2.09. In terms of profitability, SHCRW's ROE is -0.25%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, SHCRW is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
SHCRW vs HCAT Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HCAT has a market cap of 148.5M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HCAT trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HCAT's P/E ratio is 10.05. In terms of profitability, SHCRW's ROE is -0.25%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, SHCRW is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
SHCRW vs CPSI Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SHCRW's ROE is -0.25%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SHCRW is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
SHCRW vs OPRX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, OPRX has a market cap of 116.5M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while OPRX trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas OPRX's P/E ratio is 5.70. In terms of profitability, SHCRW's ROE is -0.25%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SHCRW is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
SHCRW vs AUGX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SHCRW's ROE is -0.25%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SHCRW is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
SHCRW vs CCLD Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CCLD has a market cap of 92.2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CCLD trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CCLD's P/E ratio is 8.04. In terms of profitability, SHCRW's ROE is -0.25%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
SHCRW vs DH Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while DH trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas DH's P/E ratio is 2.64. In terms of profitability, SHCRW's ROE is -0.25%, compared to DH's ROE of -0.67%. Regarding short-term risk, SHCRW is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
SHCRW vs FORA Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas FORA's P/E ratio is -24.11. In terms of profitability, SHCRW's ROE is -0.25%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SHCRW is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
SHCRW vs CCLDP Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
SHCRW vs SNCE Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SHCRW's ROE is -0.25%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SHCRW is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check SNCE's competition here
OneMedNet Corporation (NASDAQ: ONMD)
SHCRW vs ONMD Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ONMD has a market cap of 34.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ONMD trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ONMD's P/E ratio is -4.01. In terms of profitability, SHCRW's ROE is -0.25%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SHCRW is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check ONMD's competition here
Akili, Inc. (NASDAQ: AKLI)
SHCRW vs AKLI Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SHCRW's ROE is -0.25%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SHCRW is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
SHCRW vs SHLT Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SHCRW's ROE is -0.25%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SHCRW is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
SHCRW vs ONMDW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SHCRW is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check ONMDW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
SHCRW vs EUDA Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, EUDA has a market cap of 26.9M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while EUDA trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas EUDA's P/E ratio is -27.17. In terms of profitability, SHCRW's ROE is -0.25%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, SHCRW is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
SHCRW vs STRM Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas STRM's P/E ratio is -2.40. In terms of profitability, SHCRW's ROE is -0.25%, compared to STRM's ROE of -0.32%. Regarding short-term risk, SHCRW is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
SHCRW vs RNLX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SHCRW's ROE is -0.25%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SHCRW is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
SHCRW vs LIFW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SHCRW's ROE is -0.25%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SHCRW is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SHCRW vs BEATW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, BEATW has a market cap of 20.9M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas BEATW's P/E ratio is -0.06. In terms of profitability, SHCRW's ROE is -0.25%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SHCRW is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
SHCRW vs BBLN Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SHCRW's ROE is -0.25%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SHCRW is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
SHCRW vs ETAO Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SHCRW's ROE is -0.25%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SHCRW is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
SHCRW vs BFRG Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, BFRG has a market cap of 7M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while BFRG trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas BFRG's P/E ratio is -1.11. In terms of profitability, SHCRW's ROE is -0.25%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SHCRW is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
SHCRW vs SCNX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SCNX's P/E ratio is -0.16. In terms of profitability, SHCRW's ROE is -0.25%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SHCRW is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SCNX's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
SHCRW vs MGRX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MGRX has a market cap of 5.6M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MGRX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MGRX's P/E ratio is -0.41. In terms of profitability, SHCRW's ROE is -0.25%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SHCRW is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
SHCRW vs UPH Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas UPH's P/E ratio is -0.07. In terms of profitability, SHCRW's ROE is -0.25%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SHCRW is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
SHCRW vs UPH-WT Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SHCRW is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
SHCRW vs PEAR Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SHCRW's ROE is -0.25%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SHCRW is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
SHCRW vs PEARW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SHCRW's ROE is -0.25%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SHCRW is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
SHCRW vs OTRK Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SHCRW's ROE is -0.25%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SHCRW is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
SHCRW vs HCTI Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HCTI trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HCTI's P/E ratio is -0.22. In terms of profitability, SHCRW's ROE is -0.25%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SHCRW is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
SHCRW vs CMAX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SHCRW's ROE is -0.25%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SHCRW is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
SHCRW vs VSEE Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas VSEE's P/E ratio is -0.16. In terms of profitability, SHCRW's ROE is -0.25%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SHCRW is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
SHCRW vs ACON Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ACON trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ACON's P/E ratio is -0.23. In terms of profitability, SHCRW's ROE is -0.25%, compared to ACON's ROE of -0.54%. Regarding short-term risk, SHCRW is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
SHCRW vs VSEEW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SHCRW's ROE is -0.25%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SHCRW is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
SHCRW vs LIFWZ Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SHCRW is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
SHCRW vs EUDAW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, SHCRW's ROE is -0.25%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, SHCRW is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
SHCRW vs WORX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, WORX has a market cap of 586.8K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while WORX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas WORX's P/E ratio is -0.64. In terms of profitability, SHCRW's ROE is -0.25%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SHCRW is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
SHCRW vs MSPRZ Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SHCRW is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
SHCRW vs KERNW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SHCRW's ROE is -0.25%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, SHCRW is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
SHCRW vs KERN Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas KERN's P/E ratio is -0.01. In terms of profitability, SHCRW's ROE is -0.25%, compared to KERN's ROE of -0.17%. Regarding short-term risk, SHCRW is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check KERN's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
SHCRW vs ZCMD Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ZCMD has a market cap of 60.1K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ZCMD trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, SHCRW's ROE is -0.25%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SHCRW is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check ZCMD's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
SHCRW vs LIFWW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SHCRW is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
SHCRW vs CMAXW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SHCRW is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
SHCRW vs ACONW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas ACONW's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, SHCRW is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check ACONW's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
SHCRW vs SMFRW Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, SHCRW is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check SMFRW's competition here
Cue Health Inc. (NASDAQ: HLTH)
SHCRW vs HLTH Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, HLTH has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while HLTH trades at $25.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas HLTH's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, SHCRW is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check HLTH's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
SHCRW vs CHNGU Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SHCRW is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
SHCRW vs CNVY Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SHCRW's ROE is -0.25%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SHCRW is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CNVY's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
SHCRW vs CHNG Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SHCRW's ROE is -0.25%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SHCRW is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CHNG's competition here
CareCloud, Inc. (NASDAQ: MTBC)
SHCRW vs MTBC Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MTBC's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, SHCRW is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
SHCRW vs MTBCP Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check MTBCP's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
SHCRW vs MSPRV Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SHCRW is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for SHCRW.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
SHCRW vs MTBCO Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SHCRW is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check MTBCO's competition here
Cerner Corporation (NASDAQ: CERN)
SHCRW vs CERN Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CERN's P/E ratio is 55.84. In terms of profitability, SHCRW's ROE is -0.25%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SHCRW is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CERN's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
SHCRW vs AFFX Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas AFFX's P/E ratio is N/A. In terms of profitability, SHCRW's ROE is -0.25%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SHCRW is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check AFFX's competition here
Castlight Health, Inc. (NYSE: CSLT)
SHCRW vs CSLT Comparison July 2026
Sharecare, Inc. (NASDAQ: SHCRW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHCRW stands at 32.5M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SHCRW is priced at $0.09 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHCRW currently has a P/E ratio of -0.00, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SHCRW's ROE is -0.25%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SHCRW is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for SHCRW.Check CSLT's competition here